Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
about
Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthmaIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsMontelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort studyMonitoring and management of childhood asthma in asian countries: a questionnaire study.Pulmonary mucus: Pediatric perspective.Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists.Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthmaEmerging anti-inflammatory agents for allergic rhinitis.Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response.Dispensing error leading to alendronate ingestion.Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old.
P2860
Q24197585-E1EDE81F-9FB5-46F7-A433-8D64CE4F3507Q24200804-A0676F8D-B6CA-4B1F-ACFF-4A51DBF81600Q24202489-A8513963-EEE4-423A-B9DC-7870919BF168Q33443525-876C7D76-9F99-4CC0-8BD5-93CC0A43759EQ33755127-4FE42C1F-5A55-497E-8CBA-F84357997783Q34530807-AF972DF5-BA8B-495B-B7AA-165107D58907Q35196729-A3CFF641-F7B1-417F-B910-DF7940634828Q35790726-C795601E-F880-4147-89E0-28C6B22E98A2Q36217677-4B9D6540-733B-47CD-B10F-0338D88C80B6Q36302823-C727C6AB-0A15-40DF-8354-EDBE1C022BC4Q37094329-190E0476-DF1D-42E4-8657-3A546BB6C4BAQ44263681-A039D8A2-26A7-47F9-AD55-08597C900EBAQ44854809-B83F6A55-D10C-43FE-95F9-0B47D2AC9BAA
P2860
Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Montelukast: a review of its t ...... children 2 to 14 years of age.
@ast
Montelukast: a review of its t ...... children 2 to 14 years of age.
@en
Montelukast: a review of its t ...... children 2 to 14 years of age.
@nl
type
label
Montelukast: a review of its t ...... children 2 to 14 years of age.
@ast
Montelukast: a review of its t ...... children 2 to 14 years of age.
@en
Montelukast: a review of its t ...... children 2 to 14 years of age.
@nl
prefLabel
Montelukast: a review of its t ...... children 2 to 14 years of age.
@ast
Montelukast: a review of its t ...... children 2 to 14 years of age.
@en
Montelukast: a review of its t ...... children 2 to 14 years of age.
@nl
P2860
P1433
P1476
Montelukast: a review of its t ...... children 2 to 14 years of age.
@en
P2093
Richard B R Muijsers
Stuart Noble
P2860
P304
P356
10.2165/00128072-200204020-00005
P577
2002-01-01T00:00:00Z
P6179
1009924549